Validation of an Observational Scale of Dyspnea in Non-communicating Patients in the ICU

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 23, 2016

Primary Completion Date

February 23, 2017

Study Completion Date

July 28, 2017

Conditions
Dyspnea
Interventions
DRUG

Morphine

If the physician in charge of the patients judges it necessary, after the optimization of the ventilators settings, if the patient remains uncomfortable, a second therapeutic intervention using a maximum of 10mg morphine titration may be performed. After this second therapeutic intervention, a third non-verbal measure of respiratory discomfort will be performed with the IC-RDOS. Concomitantly, EEG and EMG will be again recorded over a of 15-minutes period.

Trial Locations (1)

75020

Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière Paris, France, Paris

All Listed Sponsors
lead

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

OTHER

NCT02801838 - Validation of an Observational Scale of Dyspnea in Non-communicating Patients in the ICU | Biotech Hunter | Biotech Hunter